These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
840 related articles for article (PubMed ID: 25945841)
1. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119 [TBL] [Abstract][Full Text] [Related]
3. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
4. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Zhang Z; Liu S; Shi R; Zhao G Cancer Genet; 2011 Sep; 204(9):486-91. PubMed ID: 22018270 [TBL] [Abstract][Full Text] [Related]
5. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194 [TBL] [Abstract][Full Text] [Related]
6. miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer. Hong-Yuan W; Xiao-Ping C Indian J Cancer; 2015 Dec; 52 Suppl 3():E168-71. PubMed ID: 27453416 [TBL] [Abstract][Full Text] [Related]
7. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
9. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2. Pang H; Zheng Y; Zhao Y; Xiu X; Wang J Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226 [TBL] [Abstract][Full Text] [Related]
11. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023 [TBL] [Abstract][Full Text] [Related]
12. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653 [TBL] [Abstract][Full Text] [Related]
13. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. Nam EH; Lee Y; Park YK; Lee JW; Kim S Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038 [TBL] [Abstract][Full Text] [Related]
14. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT. Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277 [TBL] [Abstract][Full Text] [Related]
15. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029 [TBL] [Abstract][Full Text] [Related]
17. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma. Wang S; Han H; Hu Y; Yang W; Lv Y; Wang L; Zhang L; Ji J Mol Carcinog; 2018 Mar; 57(3):383-392. PubMed ID: 29091326 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3. Li B; Zhang S; Shen H; Li C Biochem Biophys Res Commun; 2017 Mar; 484(2):241-247. PubMed ID: 28111340 [TBL] [Abstract][Full Text] [Related]
20. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]